Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
The purpose of this study is to determine the tolerability and efficacy in treating patients aged 51-60 with acute leukemia and in treating myelodysplastic syndromes (MDS) or myeloproliferative disorders (MPD).
Acute Disease|Myelodysplastic Syndromes|Leukemia, Myeloid, Chronic|Myeloproliferative Disorders|Blood and Marrow Transplant (BMT)|Myelodysplastic Syndromes (MDS)|Leukemia
PROCEDURE: ablative allogeneic hematopoietic cell transplantation
tolerability|efficacy of therapy
compare efficacy of this treatment to historical controls
To learn whether a new preparative regimen to prepare patients for bone marrow transplantation is useful in patients above 50 years of age and whether it is useful in patients with myelodysplastic syndromes.